title: Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase.
abstract: The mechanism of inhibition of DNA gyrase by cyclothialidine, a novel gyrase inhibitor isolated from Streptomyces filipinensis NR0484, has been studied further by using [14C]benzoylcyclothialidine and a reconstituted Escherichia coli gyrase system consisting of the A subunit, the B subunit and relaxed ColE1 DNA. The mechanism of inhibition was also studied with the 43-kDa N-terminal fragment of the B subunit. The [14C]benzoylcyclothialidine could bind to the B subunit alone but not to the A subunit nor to the plasmid DNA alone. Furthermore, the compound also bound to the 43-kDa N-terminal fragment of the B subunit. Scatchard analysis of [14C]benzoylcyclothialidine binding to DNA gyrase showed that the binding affinity of the compound increased, depending on the assembly of the gyrase (A2B2). DNA complex. This suggests that the binding site of cyclothialidine on the B subunit or its vicinity causes a conformational change during the assembly of the gyrase.DNA complex (increase in affinity: B-->A2B2-->A2B2.DNA). Furthermore, displacement curves of [14C]benzoylcyclothialidine binding by nonlabeled cyclothialidine, ATP analogues, and coumarin antibiotics indicated that cyclothialidine, coumarins, and ATP share a common (or overlapping) site of action on the B subunit of DNA gyrase; however, the microenvironment of the binding sites may differ.
authors.affiliation: Nippon Roche Research Center, Kamakura, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Nakada
authors.forename: H
authors.initials: H
authors.lastname: Gmünder
authors.forename: T
authors.initials: T
authors.lastname: Hirata
authors.forename: M
authors.initials: M
authors.lastname: Arisawa
mesh_terms: D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D049933:Aminocoumarins; D003086:Bacteriocin Plasmids; D001665:Binding Sites; D002250:Carbon Radioisotopes; D003374:Coumarins / Q000494:pharmacology; D004250:DNA Topoisomerases, Type II / Q000737:chemistry / Q000378:metabolism*; D004274:DNA, Recombinant / Q000378:metabolism; D009675:Novobiocin / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000378:metabolism*; D013302:Streptomyces / Q000201:enzymology
chemical_list: D049933:Aminocoumarins; D002250:Carbon Radioisotopes; D003374:Coumarins; D004274:DNA, Recombinant; D010456:Peptides, Cyclic; C091204:benzoylcyclothialidine; D009675:Novobiocin; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D004250:DNA Topoisomerases, Type II; C004628:coumermycin